ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Lifestyle interventions for obesity and overweight patients with severe mental illness

Lifestyle interventions for obesity and overweight patients with severe mental illness
Literature review current through: Jan 2024.
This topic last updated: Apr 06, 2022.

INTRODUCTION — Severely mentally ill individuals in the United States die earlier than members of the general population [1]. Cardiovascular disease and its associated metabolic risk factors, including obesity, are a large contributor to early mortality. Cardiovascular disease is the leading cause of death in those with severe mental illness (SMI) [2-4]. (See "Metabolic syndrome in patients with severe mental illness: Epidemiology, contributing factors, pathogenesis, and clinical implications".)

Lifestyle modification for obesity and overweight individuals focused on weight reduction and increased physical activity is the primary therapy for the management of metabolic syndrome [5-7], along with medication treatment of specific metabolic abnormalities.

This topic reviews lifestyle interventions for obesity and overweight patients with SMI. The epidemiology, pathogenesis, and clinical implications of metabolic syndrome in individuals with SMI are reviewed separately. Modifiable risk factors for cardiovascular disease in patients with SMI are also described separately. Metabolic side effects of antipsychotic medications are also reviewed separately. (See "Metabolic syndrome in patients with severe mental illness: Epidemiology, contributing factors, pathogenesis, and clinical implications" and "Modifiable risk factors for cardiovascular disease in patients with severe mental illness" and "Schizophrenia in adults: Maintenance therapy and side effect management", section on 'Metabolic dysregulation'.)

APPROACH TO TREATMENT — Our approach to treating other risk factors for cardiovascular disease in patients with severe mental illness is also reviewed separately. (See "Approach to managing increased risk for cardiovascular disease in patients with severe mental illness".)

SMI AND CARDIOVASCULAR DISEASE — Despite advances in therapy over the past decades, cardiovascular disease remains the major cause of death in most developed nations, particularly among those with severe mental illnesses (SMI) [8]. (See "Modifiable risk factors for cardiovascular disease in patients with severe mental illness".)

Factors placing individuals with SMI at greater risk for cardiovascular disease compared with the general population include:

Higher rates of tobacco use. (See "Modifiable risk factors for cardiovascular disease in patients with severe mental illness", section on 'Tobacco smoking'.)

More sedentary lives and diets with more saturated fat and fewer fruits and vegetables [2,9,10]. (See "Modifiable risk factors for cardiovascular disease in patients with severe mental illness", section on 'Overweight and Obesity'.)

Metabolic syndrome, which includes multiple risk factors for cardiovascular disease, including hypertension, obesity, and diabetes. (See "Metabolic syndrome in patients with severe mental illness: Epidemiology, contributing factors, pathogenesis, and clinical implications".)

Side effects of medications used to treat SMI, particularly the antipsychotics, including weight gain, hyperlipidemia, and glucose dysregulation [11]. (See "Schizophrenia in adults: Maintenance therapy and side effect management", section on 'Metabolic dysregulation'.)

LIFESTYLE INTERVENTIONS — Lifestyle interventions target diet, exercise, and behavior with the goals of preventing and treating obesity, cardiovascular disease, and related comorbidities. Five percent or greater weight loss has been found to decrease the risk of cardiovascular disease; improved fitness (independent of weight loss) decreases cardiovascular disease-associated mortality [12].

Key components

Psychoeducation focused on nutritional counseling

Caloric content of foods, particularly sugar-sweetened beverages, alcohol, and foods that are served in restaurants/packaged.

Appropriate portion size, with education on food labels (number of portions per package).

Recommended composition of diet, with an emphasis on fresh or frozen fruits and vegetables, whole grains, and lean meats, with reference to the healthy plate at the MyPlate website.

Information on healthy snack choices, such as those from the American Heart Association website.

Dietary and physical activity modification

Avoid alcohol and sugar-sweetened beverages.

Avoid eating out, or plan ahead when eating out. Choose restaurants with healthier menu options and try to make smart food choices whenever possible.

Avoid grazing on snacks throughout the day. Plan to eat three meals and one to two small snacks per day.

Do 30 minutes of some sort of exercise every day, such as walking.

Incorporate exercise into daily activities (take the stairs, park farther from entrance, get off the bus one stop early).

Find an exercise buddy.

Learning skills of behavioral self-management

Goal setting – Use “SMART” goal acronym:

Specific – Who? What? When? Why? How?

Measurable – How much? How many? How will I know when it is accomplished?

Attainable – Start small.

Realistic – Must be both willing and able to achieve.

Timely – Rounded within a time frame.

Regular weigh-ins.

Self-monitoring of daily food intake and activity levels, using handouts and journals.

Practice portion control by using a smaller plate and by bringing containers to restaurants to save part of the meal for later.

Engage in meal planning, grocery shopping, and food preparation.

Incorporate mindfulness into eating (do not eat in front of the television, mobile device, or computer screen) and avoid emotional eating.

Motivational enhancement — Use techniques of motivational interviewing to assist patients in exploring and resolving ambivalence concerning behavioral changes [13] (see "Substance use disorders: Motivational interviewing"):

Engage the patient by asking permission – “Could we take a moment to discuss your weight?”

Focus the conversation by providing feedback using the OARS mnemonic:

Open-ended questions that allow for the patient to express themselves – “How do you feel about your current weight?”

Affirmative statements to support positive behaviors – “You have already made a lot of changes to try and lose weight. I can tell that this is really important to you.”

Reflection to allow the patient to feel heard – “I get the feeling that you really want to lose weight, but it’s been hard for you to plan and cook meals. Tell me a little bit more about that.”

Summary statements to allow the patient to come up with steps for change – “What I’m hearing is that you have struggled with your weight for years and have tried a number of diets that haven’t seemed to work. You feel like you need to make a change but aren’t sure of what to do next.”

Provide advice and share information – “As your doctor, I would like you to know that losing weight could help with both your blood pressure and your blood sugar.”

Make a concrete plan by discussing next steps – “If you were to make a change to work on weight loss, what would the first step be?”

Close with a positive statements that emphasize patient strengths and highlight change talk – “I hear that you want to lose weight and are ready to make some changes in your diet. Your decision to cut out one soda per day shows that you are ready to start on this journey. Let’s plan to touch base by phone in two weeks to celebrate your progress and problem-solve any challenges that you are facing. We can also talk about next steps at that time.”

Addressing challenges with SMI — Lifestyle interventions for individuals with severe mental illness (SMI) should take into account a number of unique challenges faced by the SMI population. Interventions can be personalized addressing many of these factors, increasing the magnitude of intervention effects [14,15].

Socioeconomic status — Persons with SMI disproportionately suffer from poverty [16]. They may face barriers to enrolling in gym memberships, or obtaining appropriate athletic shoes or clothing for exercise. Poor neighborhoods may not provide a safe environment, prohibiting outdoor exercise.

Options for circumventing these challenges include encouraging patients to walk up and down the stairs in their residence [17], distributing exercise videos or handouts, or, if possible, providing memberships to low-cost gyms, such as the YMCA [18,19]. In-clinic exercise sessions may also overcome economic barriers to physical activity [19,20]. Local resources, such as senior centers and public parks, may be investigated as potential sites for fitness activities. Organization of group outdoor recreational activities may have the added benefit of social connectedness [21].

Poverty is also associated with poor diet, due, at least in part, to limited access to fresh fruits and in urban, impoverished areas [22,23]. Allocation of groceries and meal replacements to patients may temporarily address this problem, but long-term change requires realistically accounting for food availability and preferences. Potential solutions include accompanying patients on shopping trips to local grocery stores to demonstrate healthy options among available choices [20,24], taking participants out to nearby restaurants to help with food selection [20], and obtaining menus from local fast food restaurants and highlighting healthy choices. An alternative approach may focus on portion control rather than complicated or expensive food substitution [25].

Access to lifestyle interventions — High rates of poverty in SMI may also mean that patients are unable to afford transportation to sites offering lifestyle interventions. Problem-solving around this limitation has led to a variety of solutions [26-28]. When feasible, lifestyle modification programs may offer bus or train fare, or public transit vouchers. The convenience of locations is an important component of planning, particularly for underserved populations. Successful interventions have been staged in churches, community centers, and local schools [29-31].

A systematic assessment of the availability (outside of clinical trials) of organized lifestyle interventions for individuals with SMI is currently lacking. In the United States, an increasing emphasis on the mortality gap for individuals with SMI has led to the incorporation of lifestyle intervention programs into public mental health clinics, perhaps most notably though the Primary Care Behavioral Health Integration projects funded by the Substance and Mental Health Services Administration [32].

Psychiatric symptoms and cognitive impairment — Psychiatric symptoms may interfere with consistent treatment. Amotivation is often prominent in schizophrenia and major depression and can lead to decreased investment in the intervention and increased dropout rates.

A number of approaches can help overcome these limitations:

Group settings, rather than individual meetings, may increase motivation and self-efficacy through example and may offer peer encouragement and competition, which may decrease attrition [19].

The use of health-promoting incentives has been shown to improve outcomes [18] (eg, pedometers or blood glucose logs) [21].

The engagement of a patient’s support system may improve motivation. In other underserved populations (including African Americans and Latin Americans), family involvement is associated with increased engagement in lifestyle interventions [33].

The use of facilitators to engage with participants has been shown to improve motivation [19]. Facilitators may call patients to ensure completion of food and exercise logs, to remind participants of upcoming meetings, or to problem-solve around program nonadherence.

Positive symptoms of psychosis, particularly paranoia, can interfere with patients establishing a therapeutic alliance with lifestyle intervention facilitators [34,35]. Greater therapeutic alliance may be forged by incorporating lifestyle interventions into visits with established case managers and other known mental health providers, or through the use of peer leaders [21,36].

Patients with SMI are also impaired cognitively. Neuropsychiatric testing in this population reveals deficits in memory, executive function, attention, and processing speed [37]. Several techniques have been adopted by successful interventions to overcome cognitive deficits in participants with SMI including [24]:

Simplification of language.

Use of large font size in printed materials.

Retention has been targeted through the use of educational games, lesson repetition, frequent quizzes, and integration of mnemonic devices into modules.

To overcome low literacy rates, instructors have read aloud and used more visual materials.

Many individuals with SMI suffer from comorbid substance use disorders. A study of correlates of attendance in a healthy lifestyle intervention shows that odds of attending at least once session were significantly lower for those who reported any drug use [38]. Thus, targeting of substance use disorders is likely necessary to ensure program engagement.

Medication side effects — Side effects of psychotropic medications can interfere with participation in an effective lifestyle intervention [24]:

Sedation – Antipsychotics and many mood stabilizers are sedating. This may make exercise challenging and could inhibit attention during education sessions. Activities may need to be timed for early morning, before medications are taken, or later in the day, when sedating effects have worn off.

Anticholinergic effects – Many antipsychotics also have anticholinergic effects, including dry mouth. Patients often increase consumption of sugar-sweetened beverages to counteract this side effect, and counseling may need to directly address this behavior.

Weight gain – Weight gain occurs with many psychotropic medications. This is particularly true of the atypical antipsychotics, though most mood stabilizers and some antidepressants also have an effect on body mass index (BMI). To combat this, lifestyle interventions can be initiated when first prescribing these medications.

Information on the selection among antipsychotics and dosing to minimize weight gain and other metabolic abnormalities are reviewed separately. (See "Schizophrenia in adults: Maintenance therapy and side effect management", section on 'Metabolic dysregulation'.)

Efficacy — Aggressive lifestyle modification focused on weight reduction and increased physical activity is the primary therapy for the management of metabolic syndrome in patients in the general population [5-7]. Among patients with SMI, clinical trials of the efficacy of lifestyle interventions have been mixed. The quality of available efficacy data is limited by significant methodologic limitations including small sample sizes, short-duration interventions and variability in intervention components. Future well-designed clinical trials are needed to examine interventions that are maximally effective in those with SMI.

In our clinical experience, lifestyle interventions can help SMI patients reduce body weight and improve other metabolic abnormalities, particularly interventions that are longer in duration, have multiple treatment components, and are calibrated to meet the needs of individuals with SMI [39].

Well-regarded guidelines for psychosocial treatment of people with schizophrenia recommend that those overweight or obese (BMI >25) receive a lifestyle intervention [40].

In a meta-analysis of 17 trials, lifestyle interventions (addressing both nutrition and physical activity) for weight loss in individuals with SMI were studied [41]. Studies were grouped by intervention duration. Lifestyle interventions of ≤6 months duration (10 studies) showed greater weight reduction when compared with controls, with a standardized mean difference of -0.20, but with a high degree of heterogeneity. Lifestyle interventions of ≥12 months duration (seven studies) showed an even greater weight reduction when compared with controls (standardized mean difference of -0.24), and low statistical heterogeneity. Five of the trial interventions of ≥12 months duration achieved a mean or median weight loss of 5 percent or greater, a threshold considered to be clinically significant [41].

Further investigation of three trials with 1199 aggregate patients found that the interventions produced superior outcomes for weight, waist circumference, or body mass as compared with controls [42-50].

Other reviews of lifestyle interventions in those with SMI report similar findings of overall moderate mean weight loss in the intervention group, and mixed results in individual trials [36,39,51-55].

To date, the In SHAPE study remains one of the most successful trials of lifestyle interventions for improving cardiovascular risk in individuals with SMI. This trial randomly enrolled 133 obese (BMI >25) individuals with SMI to either lifestyle modification (the In SHAPE program) or one year of fitness club membership and education [56]. The In SHAPE program consisted of one year of weekly sessions with a fitness trainer, who also provided nutrition and resources for a healthy diet. Among the In SHAPE participants, 49 percent achieved either clinically significant increased fitness (>50 meters on the six-minute walk test) or weight loss (5 percent or greater). Participants receiving the intervention were twice as likely to walk more than 50 meters compared with those assigned to the control intervention (40 versus 20 percent). The In SHAPE intervention was also replicated in a community setting with similar outcomes [57].

Characteristics associated with better outcomes — Analyses of clinical trial data have identified features of lifestyle intervention associated with better clinical outcomes, both in patients with SMI and in the general population:

Patients with SMI — Specific elements of lifestyle interventions have been found to be associated with superior outcomes in patients with severe mental illness (SMI) [39]:

Longer duration (three or more months)

Manualized, structured approach

Focus on both nutrition and physical activity, including both educational and exercise-based sessions

Active monitoring such as weigh-ins and food diaries (rather than nutrition education alone)

Active monitoring of physical activity and fitness levels

Patients from general population — Intervention characteristics that have been shown to be associated with better outcomes of lifestyle interventions in patients drawn from general population [15]:

Use of multiple components (eg, diet, exercise, and behavioral therapy)

Personalization

More frequent contact

Training for treatment providers

MONITORING — Patients with severe mental illness should have their body weight and other potential metabolic abnormalities evaluated at minimum annually, and more frequently during the first year after initiating an antipsychotic drug, or if they have other factors placing them at risk of obesity (eg, a sedentary lifestyle or diabetes). A table describes a recommended monitoring schedule for patients initiating antipsychotic medication (table 1) [58]. Monitoring for metabolic abnormalities is reviewed in greater detail separately. (See "Modifiable risk factors for cardiovascular disease in patients with severe mental illness".)

SOCIETY GUIDELINE LINKS — Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See "Society guideline links: Obesity in adults".)

SUMMARY

Our approach to treating other risk factors for cardiovascular disease in patients with severe mental illness (SMI) is reviewed separately. (See "Approach to managing increased risk for cardiovascular disease in patients with severe mental illness".)

Patients with SMI have a greater risk of being overweight and of obesity compared with the general population because of more sedentary lifestyles, poorer diets, and side effects of medicines to treat SMI, particularly antipsychotic medications. Obesity places them at a greater risk of cardiovascular disease. (See 'SMI and cardiovascular disease' above and "Metabolic syndrome in patients with severe mental illness: Epidemiology, contributing factors, pathogenesis, and clinical implications", section on 'Risk of cardiovascular disease'.)

Lifestyle interventions target diet, exercise, and behavior with the goals of preventing and treating obesity, cardiovascular disease, and related comorbidities. Five percent or greater weight loss has been found to decrease the risk of cardiovascular disease. Improved fitness decreases cardiovascular disease-associated mortality. (See 'Lifestyle interventions' above.)

Key components of lifestyle interventions include (see 'Key components' above):

Psychoeducation focused on nutrition

Dietary and physical activity modification

Learning skills of behavioral self-management

Motivational enhancement

Modifications to these interventions for SMI patients include (see 'Addressing challenges with SMI' above):

Making dietary and activity modifications feasible given low socioeconomic status

Making interventions accessible (eg, local community centers and public transit)

Addressing obstacles posed by psychiatric symptoms and medication side effects

Among patients with SMI, clinical trials have shown mixed findings on the efficacy of lifestyle interventions. In our clinical experience, however, lifestyle interventions – particularly those modified to address challenges faced by SMI patients – can help them reduce body weight and improve other metabolic abnormalities. (See 'Efficacy' above.)

Interventions of longer duration, using a structured, manualized approach, focused on both nutrition and physical activity, and employing active monitoring have been found to be associated with superior outcomes. (See 'Characteristics associated with better outcomes' above.)

  1. Druss BG, Zhao L, Von Esenwein S, et al. Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med Care 2011; 49:599.
  2. McCreadie RG, Scottish Schizophrenia Lifestyle Group. Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br J Psychiatry 2003; 183:534.
  3. Compton MT, Daumit GL, Druss BG. Cigarette smoking and overweight/obesity among individuals with serious mental illnesses: a preventive perspective. Harv Rev Psychiatry 2006; 14:212.
  4. Osborn DP, Nazareth I, King MB. Physical activity, dietary habits and Coronary Heart Disease risk factor knowledge amongst people with severe mental illness: a cross sectional comparative study in primary care. Soc Psychiatry Psychiatr Epidemiol 2007; 42:787.
  5. Magkos F, Yannakoulia M, Chan JL, Mantzoros CS. Management of the metabolic syndrome and type 2 diabetes through lifestyle modification. Annu Rev Nutr 2009; 29:223.
  6. Bassi N, Karagodin I, Wang S, et al. Lifestyle modification for metabolic syndrome: a systematic review. Am J Med 2014; 127:1242.e1.
  7. Bozkurt B, Aguilar D, Deswal A, et al. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association. Circulation 2016; 134:e535.
  8. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119:e21.
  9. Brown S, Birtwistle J, Roe L, Thompson C. The unhealthy lifestyle of people with schizophrenia. Psychol Med 1999; 29:697.
  10. Strassnig M, Brar JS, Ganguli R. Nutritional assessment of patients with schizophrenia: a preliminary study. Schizophr Bull 2003; 29:393.
  11. De Hert M, Detraux J, van Winkel R, et al. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol 2011; 8:114.
  12. Klein S, Burke LE, Bray GA, et al. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2004; 110:2952.
  13. Miller WR, Rolinick S. Motivational interviewing: helping people change, Guilford Press, New York 2013.
  14. Eyles HC, Mhurchu CN. Does tailoring make a difference? A systematic review of the long-term effectiveness of tailored nutrition education for adults. Nutr Rev 2009; 67:464.
  15. Ward MC, White DT, Druss BG. A meta-review of lifestyle interventions for cardiovascular risk factors in the general medical population: lessons for individuals with serious mental illness. J Clin Psychiatry 2015; 76:e477.
  16. Saraceno B, Levav I, Kohn R. The public mental health significance of research on socio-economic factors in schizophrenia and major depression. World Psychiatry 2005; 4:181.
  17. Lowe T, Lubos E. Effectiveness of weight management interventions for people with serious mental illness who receive treatment with atypical antipsychotic medications. A literature review. J Psychiatr Ment Health Nurs 2008; 15:857.
  18. Loh C, Meyer JM, Leckband SG. A comprehensive review of behavioral interventions for weight management in schizophrenia. Ann Clin Psychiatry 2006; 18:23.
  19. Roberts SH, Bailey JE. Incentives and barriers to lifestyle interventions for people with severe mental illness: a narrative synthesis of quantitative, qualitative and mixed methods studies. J Adv Nurs 2011; 67:690.
  20. Bradshaw T, Lovell K, Harris N. Healthy living interventions and schizophrenia: a systematic review. J Adv Nurs 2005; 49:634.
  21. Kemp V, Bates A, Isaac M. Behavioural interventions to reduce the risk of physical illness in persons living with mental illness. Curr Opin Psychiatry 2009; 22:194.
  22. Leung CW, Ding EL, Catalano PJ, et al. Dietary intake and dietary quality of low-income adults in the Supplemental Nutrition Assistance Program. Am J Clin Nutr 2012; 96:977.
  23. Baker EA, Schootman M, Barnidge E, Kelly C. The role of race and poverty in access to foods that enable individuals to adhere to dietary guidelines. Prev Chronic Dis 2006; 3:A76.
  24. Cabassa LJ, Ezell JM, Lewis-Fernández R. Lifestyle interventions for adults with serious mental illness: a systematic literature review. Psychiatr Serv 2010; 61:774.
  25. Ganguli R. Behavioral therapy for weight loss in patients with schizophrenia. J Clin Psychiatry 2007; 68 Suppl 4:19.
  26. McCabe MP, Leas L. A qualitative study of primary health care access, barriers and satisfaction among people with mental illness. Psychol Health Med 2008; 13:303.
  27. Bauer MS, Williford WO, McBride L, et al. Perceived barriers to health care access in a treated population. Int J Psychiatry Med 2005; 35:13.
  28. Galletly CL, Murray LE. Managing weight in persons living with severe mental illness in community settings: a review of strategies used in community interventions. Issues Ment Health Nurs 2009; 30:660.
  29. Johnson M, Everson-Hock E, Jones R, et al. What are the barriers to primary prevention of type 2 diabetes in black and minority ethnic groups in the UK? A qualitative evidence synthesis. Diabetes Res Clin Pract 2011; 93:150.
  30. Osei-Assibey G, Kyrou I, Adi Y, et al. Dietary and lifestyle interventions for weight management in adults from minority ethnic/non-White groups: a systematic review. Obes Rev 2010; 11:769.
  31. Satterfield DW, Volansky M, Caspersen CJ, et al. Community-based lifestyle interventions to prevent type 2 diabetes. Diabetes Care 2003; 26:2643.
  32. Druss BG, Chwastiak L, Kern J, et al. Psychiatry's Role in Improving the Physical Health of Patients With Serious Mental Illness: A Report From the American Psychiatric Association. Psychiatr Serv 2018; 69:254.
  33. Seo DC, Sa J. A meta-analysis of psycho-behavioral obesity interventions among US multiethnic and minority adults. Prev Med 2008; 47:573.
  34. Kilbourne AM, McCarthy JF, Post EP, et al. Access to and satisfaction with care comparing patients with and without serious mental illness. Int J Psychiatry Med 2006; 36:383.
  35. Lester H, Tritter JQ, England E. Satisfaction with primary care: the perspectives of people with schizophrenia. Fam Pract 2003; 20:508.
  36. Faulkner G, Soundy AA, Lloyd K. Schizophrenia and weight management: a systematic review of interventions to control weight. Acta Psychiatr Scand 2003; 108:324.
  37. Reichenberg A, Harvey PD, Bowie CR, et al. Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophr Bull 2009; 35:1022.
  38. Tuda D, Stefancic A, Hawes M, et al. Correlates of Attendance in a Peer-Led Healthy Lifestyle Intervention for People with Serious Mental Illness Living in Supportive Housing. Community Ment Health J 2022; 58:761.
  39. Bartels S. Desilets R. Health Promotion Programs for People with Serious Mental Illness (Prepared by the Dartmouth Health Promotion Research Team). SAMHSA-HRSA Center for Integrated Health Solutions, Washington DC 2012. http://www.integration.samhsa.gov/Health_Promotion_White_Paper_Bartels_Final_Document.pdf (Accessed on March 17, 2016).
  40. Dixon LB, Dickerson F, Bellack AS, et al. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull 2010; 36:48.
  41. Naslund JA, Whiteman KL, McHugo GJ, et al. Lifestyle interventions for weight loss among overweight and obese adults with serious mental illness: A systematic review and meta-analysis. Gen Hosp Psychiatry 2017; 47:83.
  42. Looijmans A, Stiekema APM, Bruggeman R, et al. Changing the obesogenic environment to improve cardiometabolic health in residential patients with a severe mental illness: cluster randomised controlled trial. Br J Psychiatry 2017; 211:296.
  43. Aschbrenner KA, Naslund JA, Gorin AA, et al. Group Lifestyle Intervention With Mobile Health for Young Adults With Serious Mental Illness: A Randomized Controlled Trial. Psychiatr Serv 2022; 73:141.
  44. Cabassa LJ, Stefancic A, Lewis-Fernández R, et al. Main Outcomes of a Peer-Led Healthy Lifestyle Intervention for People With Serious Mental Illness in Supportive Housing. Psychiatr Serv 2021; 72:555.
  45. Erickson ZD, Mena SJ, Pierre JM, et al. Behavioral interventions for antipsychotic medication-associated obesity: a randomized, controlled clinical trial. J Clin Psychiatry 2016; 77:e183.
  46. Fernández Guijarro S, Pomarol-Clotet E, Rubio Muñoz MC, et al. Effectiveness of a community-based nurse-led lifestyle-modification intervention for people with serious mental illness and metabolic syndrome. Int J Ment Health Nurs 2019; 28:1328.
  47. Looijmans A, Jörg F, Bruggeman R, et al. Multimodal lifestyle intervention using a web-based tool to improve cardiometabolic health in patients with serious mental illness: results of a cluster randomized controlled trial (LION). BMC Psychiatry 2019; 19:339.
  48. Luciano M, Sampogna G, Amore M, et al. How to improve the physical health of people with severe mental illness? A multicentric randomized controlled trial on the efficacy of a lifestyle group intervention. Eur Psychiatry 2021; 64:e72.
  49. Tsodikov F, Schechter M, Goldsmith R, et al. The effect of lifestyle intervention on cardiometabolic risk factors in mental health rehabilitation hostel residents at-risk: a cluster-randomized controlled 15-month trial. Int J Obes (Lond) 2022; 46:926.
  50. Williams J, Stubbs B, Richardson S, et al. 'Walk this way': results from a pilot randomised controlled trial of a health coaching intervention to reduce sedentary behaviour and increase physical activity in people with serious mental illness. BMC Psychiatry 2019; 19:287.
  51. Verhaeghe N, De Maeseneer J, Maes L, et al. Effectiveness and cost-effectiveness of lifestyle interventions on physical activity and eating habits in persons with severe mental disorders: a systematic review. Int J Behav Nutr Phys Act 2011; 8:28.
  52. Alvarez-Jiménez M, Hetrick SE, González-Blanch C, et al. Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry 2008; 193:101.
  53. Bonfioli E, Berti L, Goss C, et al. Health promotion lifestyle interventions for weight management in psychosis: a systematic review and meta-analysis of randomised controlled trials. BMC Psychiatry 2012; 12:78.
  54. Gabriele JM, Dubbert PM, Reeves RR. Efficacy of behavioural interventions in managing atypical antipsychotic weight gain. Obes Rev 2009; 10:442.
  55. Gierisch JM, Nieuwsma JA, Bradford DW, et al. Interventions To Improve Cardiovascular Risk Factors in People With Serious Mental Illness. Agency for Healthcare Research and Quality, Publication no. 13-EHC063-EF, US Department of Health and Human Services, Rockville 2013. http://www.ncbi.nlm.nih.gov/books/NBK138237/pdf/Bookshelf_NBK138237.pdf (Accessed on March 23, 2016).
  56. Bartels SJ, Pratt SI, Aschbrenner KA, et al. Clinically significant improved fitness and weight loss among overweight persons with serious mental illness. Psychiatr Serv 2013; 64:729.
  57. Bartels SJ, Pratt SI, Aschbrenner KA, et al. Pragmatic replication trial of health promotion coaching for obesity in serious mental illness and maintenance of outcomes. Am J Psychiatry 2015; 172:344.
  58. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004; 27:596.
Topic 105454 Version 7.0

References

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟